Vericel, formerly Aastrom, in which Dr. Wotton is now a BOD member has its own very successful Patented Bio-reactors, in which its uses the DCM and CLI autologous bone marrow extracted to concentrate stem cells specific to restore healing tissues. While $OCAT is primarily an ESC biotech it also develops ASC therapies. ASC therapies do not require anti-rejection chemicals for those critical tissues related to non-immune privileged body functions such as heart, cartilage, and capillaries.
News 
Market Data 
Discover 
